423 related articles for article (PubMed ID: 18158732)
21. Role of tumor necrosis factor receptors in regulating CD8 T-cell responses during acute lymphocytic choriomeningitis virus infection.
Suresh M; Singh A; Fischer C
J Virol; 2005 Jan; 79(1):202-13. PubMed ID: 15596816
[TBL] [Abstract][Full Text] [Related]
22. Targeting of non-dominant antigens as a vaccine strategy to broaden T-cell responses during chronic viral infection.
Holst PJ; Jensen BA; Ragonnaud E; Thomsen AR; Christensen JP
PLoS One; 2015; 10(2):e0117242. PubMed ID: 25679375
[TBL] [Abstract][Full Text] [Related]
23. Differential immune recognition of LCMV nucleoprotein and glycoprotein in transgenic mice expressing LCMV cDNA genes.
Zeller JC; Nguyen N; Southern PJ
Virology; 1997 May; 231(2):290-300. PubMed ID: 9168891
[TBL] [Abstract][Full Text] [Related]
24. In vivo dynamics of anti-viral CD8 T cell responses to different epitopes. An evaluation of bystander activation in primary and secondary responses to viral infection.
Murali-Krishna K; Altman JD; Suresh M; Sourdive D; Zajac A; Ahmed R
Adv Exp Med Biol; 1998; 452():123-42. PubMed ID: 9889966
[TBL] [Abstract][Full Text] [Related]
25. Immunoproteasomes down-regulate presentation of a subdominant T cell epitope from lymphocytic choriomeningitis virus.
Basler M; Youhnovski N; Van Den Broek M; Przybylski M; Groettrup M
J Immunol; 2004 Sep; 173(6):3925-34. PubMed ID: 15356141
[TBL] [Abstract][Full Text] [Related]
26. CD8+ T cell immunodominance in lymphocytic choriomeningitis virus infection is modified in the presence of toll-like receptor agonists.
Siddiqui S; Basta S
J Virol; 2011 Dec; 85(24):13224-33. PubMed ID: 21957295
[TBL] [Abstract][Full Text] [Related]
27. Evolution of the T cell repertoire during primary, memory, and recall responses to viral infection.
Blattman JN; Sourdive DJ; Murali-Krishna K; Ahmed R; Altman JD
J Immunol; 2000 Dec; 165(11):6081-90. PubMed ID: 11086040
[TBL] [Abstract][Full Text] [Related]
28. Nucleoprotein-specific nonneutralizing antibodies speed up LCMV elimination independently of complement and FcγR.
Straub T; Schweier O; Bruns M; Nimmerjahn F; Waisman A; Pircher H
Eur J Immunol; 2013 Sep; 43(9):2338-48. PubMed ID: 23749409
[TBL] [Abstract][Full Text] [Related]
29. In vivo induction of a high-avidity, high-frequency cytotoxic T-lymphocyte response is associated with antiviral protective immunity.
Sedlik C; Dadaglio G; Saron MF; Deriaud E; Rojas M; Casal SI; Leclerc C
J Virol; 2000 Jul; 74(13):5769-75. PubMed ID: 10846055
[TBL] [Abstract][Full Text] [Related]
30. Increasing viral dose causes a reversal in CD8+ T cell immunodominance during primary influenza infection due to differences in antigen presentation, T cell avidity, and precursor numbers.
Luciani F; Sanders MT; Oveissi S; Pang KC; Chen W
J Immunol; 2013 Jan; 190(1):36-47. PubMed ID: 23233728
[TBL] [Abstract][Full Text] [Related]
31. Qualitative and quantitative analysis of adenovirus type 5 vector-induced memory CD8 T cells: not as bad as their reputation.
Steffensen MA; Holst PJ; Steengaard SS; Jensen BA; Bartholdy C; Stryhn A; Christensen JP; Thomsen AR
J Virol; 2013 Jun; 87(11):6283-95. PubMed ID: 23536658
[TBL] [Abstract][Full Text] [Related]
32. Analysis of cytotoxic T cell responses to dominant and subdominant epitopes during acute and chronic lymphocytic choriomeningitis virus infection.
van der Most RG; Sette A; Oseroff C; Alexander J; Murali-Krishna K; Lau LL; Southwood S; Sidney J; Chesnut RW; Matloubian M; Ahmed R
J Immunol; 1996 Dec; 157(12):5543-54. PubMed ID: 8955205
[TBL] [Abstract][Full Text] [Related]
33. Using recombinant coxsackievirus B3 to evaluate the induction and protective efficacy of CD8+ T cells during picornavirus infection.
Slifka MK; Pagarigan R; Mena I; Feuer R; Whitton JL
J Virol; 2001 Mar; 75(5):2377-87. PubMed ID: 11160741
[TBL] [Abstract][Full Text] [Related]
34. Cell-intrinsic defects in the proliferative response of antiviral memory CD8 T cells in aged mice upon secondary infection.
Decman V; Laidlaw BJ; Dimenna LJ; Abdulla S; Mozdzanowska K; Erikson J; Ertl HC; Wherry EJ
J Immunol; 2010 May; 184(9):5151-9. PubMed ID: 20368274
[TBL] [Abstract][Full Text] [Related]
35. Antiviral cytotoxic T-cell memory by vaccination with recombinant Listeria monocytogenes.
Slifka MK; Shen H; Matloubian M; Jensen ER; Miller JF; Ahmed R
J Virol; 1996 May; 70(5):2902-10. PubMed ID: 8627765
[TBL] [Abstract][Full Text] [Related]
36. IFN-induced attrition of CD8 T cells in the presence or absence of cognate antigen during the early stages of viral infections.
Bahl K; Kim SK; Calcagno C; Ghersi D; Puzone R; Celada F; Selin LK; Welsh RM
J Immunol; 2006 Apr; 176(7):4284-95. PubMed ID: 16547266
[TBL] [Abstract][Full Text] [Related]
37. PD-L1 Checkpoint Inhibition Narrows the Antigen-Specific T Cell Receptor Repertoire in Chronic Lymphocytic Choriomeningitis Virus Infection.
Klein S; Ghersi D; Manns MP; Prinz I; Cornberg M; Kraft ARM
J Virol; 2020 Aug; 94(18):. PubMed ID: 32641478
[TBL] [Abstract][Full Text] [Related]
38. Different dynamics of CD4+ and CD8+ T cell responses during and after acute lymphocytic choriomeningitis virus infection.
De Boer RJ; Homann D; Perelson AS
J Immunol; 2003 Oct; 171(8):3928-35. PubMed ID: 14530309
[TBL] [Abstract][Full Text] [Related]
39. Quantitating the magnitude of the lymphocytic choriomeningitis virus-specific CD8 T-cell response: it is even bigger than we thought.
Masopust D; Murali-Krishna K; Ahmed R
J Virol; 2007 Feb; 81(4):2002-11. PubMed ID: 17151096
[TBL] [Abstract][Full Text] [Related]
40. Anti-viral protection and prevention of lymphocytic choriomeningitis or of the local footpad swelling reaction in mice by immunization with vaccinia-recombinant virus expressing LCMV-WE nucleoprotein or glycoprotein.
Hany M; Oehen S; Schulz M; Hengartner H; Mackett M; Bishop DH; Overton H; Zinkernagel RM
Eur J Immunol; 1989 Mar; 19(3):417-24. PubMed ID: 2468501
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
